BIOGEN INC. Litigation Settlement, Amount (Deprecated 2017-01-31)
BIOGEN INC. (BIIB) reported Litigation Settlement, Amount (Deprecated 2017-01-31) of $1.25 billion for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-04-25.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmount · last filed 2017-04-25
- BIOGEN INC. litigation settlement, amount (deprecated 2017-01-31) for the quarter ending 2017-03-31 was $1.25B.
- BIOGEN INC. litigation settlement, amount (deprecated 2017-01-31) for fiscal 2016 was $1.25B.
| Period end | Litigation Settlement, Amount (Deprecated 2017-01-31) 3 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 12 month |
|---|---|---|
| 2017-03-31 | $1.25B 10-Q · filed 2017-04-25 | |
| 2016-12-31 | $1.25B 10-K · filed 2017-02-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |